Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain

European Journal of Pain

Volumn 14, Issue 2, 2010, Pages 127.e1-127.e8

  Gormsen, Lise ^a   Rosenberg, Raben ^a   Bach, Flemming W ^b   Jensen, Troels S ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Anxiety; Chronic pain; Depression; Fibromyalgia; Mental distress; Neuropathic pain

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; FIBROMYALGIA; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MALE; MENTAL STRESS; NEUROPATHIC PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 74649087430     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2009.03.010     Document Type: Article

References (66)

1. Ahles T.A., Khan S.A., Yunus M.B., Spiegel D.A., and Masi A.T. Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry 148 (1991) 1721-1726
2. Arnold L.M. Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res Ther 8 (2006) 212
3. Arnold L.M., Lu Y., Crofford L.J., Wohlreich M., Detke M.J., Iyengar S., et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50 (2004) 2974-2984
4. Arnold L.M., Rosen A., Pritchett Y.L., D'Souza D.N., Goldstein D.J., Iyengar S., et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 119 (2005) 5-15
5. Bair M.J., Robinson R.L., Katon W., and Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 163 (2003) 2433-2445
6. Bech P, Licht R, Stage K, Abilgaard W, Bech-Andersen G, Sondergaard S. Rating scales for affektive lidelser. Psykiatrisk Forskningsenhed, Psykiatrisk Sygehus, Hillerod, Frederiksborg Amt; 2005.
7. Bech P., Rasmussen N.A., Olsen L.R., Noerholm V., and Abildgaard W. The sensitivity and specificity of the major depression inventory, using the present state examination as the index of diagnostic validity. J Affect Disord 66 (2001) 159-164
8. Bennett R. Fibromyalgia: present to future. Curr Rheumatol Rep 7 (2005) 371-376
9. Berger A., Dukes E.M., and Oster G. Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 5 (2004) 143-149
10. Bergman S., Jacobsson L.T., Herrstrom P., and Petersson I.F. Health status as measured by SF-36 reflects changes and predicts outcome in chronic musculoskeletal pain: a 3-year follow up study in the general population. Pain 108 (2004) 115-123
11. Bjorner J, Damsgaard M. Dansk manual til SF-36. Et sporgeskema om helbredsstatus. Kobenhavn, Laegemiddelindustriforeningen; 1997.
12. Bradley L.A. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry 69 2 (2008) 6-13
13. Bymaster F.P., Dreshfield-Ahmad L.J., Threlkeld P.G., Shaw J.L., Thompson L., Nelson D.L., et al. Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 25 (2001) 871-880
14. Dersh J., Polatin P.B., and Gatchel R.J. Chronic pain and psychopathology: research findings and theoretical considerations. Psychosom Med 64 (2002) 773-786
15. Dworkin R.H., and Caligor E. Psychiatric diagnosis and chronic pain: DSM-III-R and beyond. J Pain Symptom Manage 3 (1988) 87-98
16. Edwards R.R., Smith M.T., Kudel I., and Haythornthwaite J. Pain-related catastrophizing as a risk factor for suicidal ideation in chronic pain. Pain 126 (2006) 272-279
17. Epstein S.A., Kay G., Clauw D., Heaton R., Klein D., Krupp L., et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 40 (1999) 57-63
18. Finnerup N.B., Sindrup S.H., and Jensen T.S. Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam Clin Pharmacol 21 (2007) 129-136
19. Goldstein D.J., Lu Y., Detke M.J., Lee T.C., and Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116 (2005) 109-118
20. Gustorff B., Dorner T., Likar R., Grisold W., Lawrence K., Schwarz F., et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol Scand 52 (2008) 132-136
21. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
22. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
23. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6 (1967) 278-296
24. Hamilton M. Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154 (1989) 201-206
25. Haythornthwaite J.A., and Benrud-Larson L.M. Psychological aspects of neuropathic pain. Clin J Pain 16 (2000) 101-105
26. Haythornthwaite J.A., Sieber W.J., and Kerns R.D. Depression and the chronic pain experience. Pain 46 (1991) 177-184
27. Hudson J.I., Hudson M.S., Pliner L.F., Goldenberg D.L., and Pope Jr. H.G. Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 142 (1985) 441-446
28. Hudson J.I., Mangweth B., Pope Jr. H.G., De Col C., Hausmann A., Gutweniger S., et al. Family study of affective spectrum disorder. Arch Gen Psychiatry 60 (2003) 170-177
29. Jensen T.S., and Baron R. Translation of symptoms and signs into mechanisms in neuropathic pain. Pain 102 (2003) 1-8
30. Jones J., Rutledge D.N., Jones K.D., Matallana L., and Rooks D.S. Self-assessed physical function levels of women with fibromyalgia: a national survey. Womens Health Issues 18 (2008) 406-412
31. Kapczinski F., Lima M.S., Souza J.S., and Schmitt R. Antidepressants for generalized anxiety disorder. Cochrane Database Syst Rev (2003) CD003592
32. Krag N.J., Norregaard J., Larsen J.K., and Danneskiold-Samsoe B. A blinded, controlled evaluation of anxiety and depressive symptoms in patients with fibromyalgia, as measured by standardized psychometric interview scales. Acta Psychiatr Scand 89 (1994) 370-375
33. Lautenbacher S., and Krieg J.C. Pain perception in psychiatric disorders: a review of the literature. J Psychiatr Res 28 (1994) 109-122
34. Loldrup D., Langemark M., Hansen H.J., Olesen J., and Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology (Berl) 99 (1989) 1-7
35. Max M.B., Culnane M., Schafer S.C., Gracely R.H., Walther D.J., Smoller B., et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology 37 (1987) 589-596
36. McCarberg B. Managing the comorbidities of postherpetic neuralgia. J Am Acad Nurse Pract 15 (2003) 16-21
37. McLean S.A., and Clauw D.J. Biomedical models of fibromyalgia. Disabil Rehabil 27 (2005) 659-665
38. Melzack R., Katz J., and Wall P.D. Pain measurements in persons in pain. In: Melzack R., Katz J., and Wall P.D. (Eds). Textbook of pain Edinburgh (1994), Churchill Livingstone, London, Madrid, Melbourne, New York and Tokyo 337-351
39. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
40. Mongini F., Ciccone G., Ceccarelli M., Baldi I., and Ferrero L. Muscle tenderness in different types of facial pain and its relation to anxiety and depression: a cross-sectional study on 649 patients. Pain 131 (2007) 106-111
41. NCCMH (National Collaborating Centre for Mental Health). Depression: management of depression in primary and secondary care - national clinical practice. London: The British Psychological Society and Gaskell, vol. 23: 2004. p. 1-362.
42. Nicholson B., and Verma S. Comorbidities in chronic neuropathic pain. Pain Med 5 1 (2004) 9-27
43. Olsen L.R., Jensen D.V., Noerholm V., Martiny K., and Bech P. The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychol Med 33 (2003) 351-356
44. Olsen L.R., Mortensen E.L., and Bech P. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand 109 (2004) 96-103
45. Olsen L.R., Mortensen E.L., and Bech P. The SCL-90 and SCL-90R versions validated by item response models in a Danish community sample. Acta Psychiatr Scand 110 (2004) 225-229
46. Otto M., Bach F.W., Jensen T.S., and Sindrup S.H. Health-related quality of life and its predictive role for analgesic effect in patients with painful polyneuropathy. Eur J Pain 11 (2007) 572-578
47. Pagano T., Matsutani L.A., Ferreira E.A., Marques A.P., and Pereira C.A. Assessment of anxiety and quality of life in fibromyalgia patients. Sao Paulo Med J 122 (2004) 252-258
48. Porreca F., Ossipov M.H., and Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci 25 (2002) 319-325
49. Rasmussen P.V., Sindrup S.H., Jensen T.S., and Bach F.W. Symptoms and signs in patients with suspected neuropathic pain. Pain 110 (2004) 461-469
50. Rasmussen P.V., Sindrup S.H., Jensen T.S., and Bach F.W. Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion. Eur J Neurol 11 (2004) 545-553
51. Schweinhardt P., Sauro K.M., and Bushnell M.C. Fibromyalgia: a disorder of the brain?. Neuroscientist (2008)
52. Sindrup S.H., and Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 83 (1999) 389-400
53. Smith M.T., Edwards R.R., Robinson R.C., and Dworkin R.H. Suicidal ideation, plans, and attempts in chronic pain patients: factors associated with increased risk. Pain 111 (2004) 201-208
54. Smith M.T., Perlis M.L., and Haythornthwaite J.A. Suicidal ideation in outpatients with chronic musculoskeletal pain: an exploratory study of the role of sleep onset insomnia and pain intensity. Clin J Pain 20 (2004) 111-118
55. Stahl S., and Briley M. Understanding pain in depression. Hum Psychopharmacol 19 1 (2004) 9-13
56. Stahl S.M. Brainstorms: symptoms and circuits, part 2: anxiety disorders. J Clin Psychiatry 64 (2003) 1408-1409
57. Suzuki R., and Dickenson A. Spinal and supraspinal contributions to central sensitization in peripheral neuropathy. Neurosignals 14 (2005) 175-181
58. Suzuki R., Rygh L.J., and Dickenson A.H. Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 25 (2004) 613-617
59. Svendsen K.B., Jensen T.S., Hansen H.J., and Bach F.W. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 114 (2005) 473-481
60. Treede R.D., Jensen T.S., Campbell J.N., Cruccu G., Dostrovsky J.O., Griffin J.W., et al. Neuropathic pain. Redefinition and a grading system for clinical and research purposes. Neurology (2007)
61. Usui C., Doi N., Nishioka M., Komatsu H., Yamamoto R., Ohkubo T., et al. Electroconvulsive therapy improves severe pain associated with fibromyalgia. Pain 121 (2006) 276-280
62. van Balkom A.J., Bakker A., Spinhoven P., Blaauw B.M., Smeenk S., and Ruesink B. A meta-analysis of the treatment of panic disorder with or without agoraphobia: a comparison of psychopharmacological, cognitive-behavioral, and combination treatments. J Nerv Ment Dis 185 (1997) 510-516
63. Witting N., Svensson P., and Jensen T.S. Differential recruitment of endogenous pain inhibitory systems in neuropathic pain patients. Pain 103 (2003) 75-81
64. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum,vol. 33; 1990. p. 160-172.
65. Woolf C.J. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci 74 (2004) 2605-2610
66. Woolf C.J., and Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1954-1959